Hidde Ploegh
Hidde Ploegh
Senior Investigator, Program in Cellular and Molecular Medicine, Boston Children's Hospital
Verified email at childrens.harvard.edu
Title
Cited by
Cited by
Year
Molecular cell biology
H Lodish, A Berk, CA Kaiser, M Krieger, MP Scott, A Bretscher, H Ploegh, ...
Macmillan, 2008
99782008
CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance
JH Niess, S Brand, X Gu, L Landsman, S Jung, BA McCormick, JM Vyas, ...
Science 307 (5707), 254-258, 2005
15942005
Genome-scale CRISPR-mediated control of gene repression and activation
LA Gilbert, MA Horlbeck, B Adamson, JE Villalta, Y Chen, EH Whitehead, ...
Cell 159 (3), 647-661, 2014
13502014
Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction
EJHJ Wiertz, D Tortorella, M Bogyo, J Yu, W Mothes, TR Jones, ...
Nature 384 (6608), 432-438, 1996
13011996
The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol
EJHJ Wiertz, TR Jones, L Sun, M Bogyo, HJ Geuze, HL Ploegh
Cell 84 (5), 769-779, 1996
12341996
Empty MHC class I molecules come out in the cold
HG Ljunggren, NJ Stam, C Öhlén, JJ Neefjes, P Höglund, MT Heemels, ...
Nature 346 (6283), 476-480, 1990
9921990
Herpes simplex virus turns off the TAP to evade host immunity
A Hill, P Jugovic, G Russ, J Bennink, J Yewdell, H Ploegh, D Johnson
Nature 375 (6530), 411-415, 1995
9801995
Viral subversion of the immune system
D Tortorella, BE Gewurz, MH Furman, DJ Schust, HL Ploegh
Annual review of immunology 18 (1), 861-926, 2000
9482000
Viral strategies of immune evasion
HL Ploegh
Science 280 (5361), 248-253, 1998
9211998
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
T Maruyama, SK Dougan, MC Truttmann, AM Bilate, JR Ingram, ...
Nature biotechnology 33 (5), 538-542, 2015
7982015
A membrane protein required for dislocation of misfolded proteins from the ER
BN Lilley, HL Ploegh
Nature 429 (6994), 834-840, 2004
7612004
TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4− 8+ T cells
L Van Kaer, PG Ashton-Rickardt, HL Ploegh, S Tonegawa
Cell 71 (7), 1205-1214, 1992
7551992
Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments
PJ Peters, JJ Neefjes, V Oorschot, HL Ploegh, HJ Geuze
Nature 349 (6311), 669-676, 1991
7431991
Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus
T Nakagawa, W Roth, P Wong, A Nelson, A Farr, J Deussing, ...
Science 280 (5362), 450-453, 1998
7281998
The known unknowns of antigen processing and presentation
JM Vyas, AG Van der Veen, HL Ploegh
Nature Reviews Immunology 8 (8), 607-618, 2008
6582008
Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase
RA Gruters, JJ Neefjes, M Tersmette, REY de Goede, A Tulp, ...
Nature 330 (6143), 74-77, 1987
6551987
UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes
YM Kim, MM Brinkmann, ME Paquet, HL Ploegh
Nature 452 (7184), 234-238, 2008
6542008
Multiple associated proteins regulate proteasome structure and function
DS Leggett, J Hanna, A Borodovsky, B Crosas, M Schmidt, RT Baker, ...
Molecular cell 10 (3), 495-507, 2002
6452002
Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis
HY Cohen, S Lavu, KJ Bitterman, B Hekking, TA Imahiyerobo, C Miller, ...
Molecular cell 13 (5), 627-638, 2004
6402004
Essential role for cathepsin S in MHC class II–associated invariant chain processing and peptide loading
RJ Riese, PR Wolf, D Brömme, LR Natkin, JA Villadangos, HL Ploegh, ...
Immunity 4 (4), 357-366, 1996
6131996
The system can't perform the operation now. Try again later.
Articles 1–20